BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes - sg.finance.yahoo.com
- news.google.com language
- 2025-08-14 03:05 event
- 1 week ago schedule